Terms: = Thyroid cancer AND MSH6, GTBP, P52701, 2956, ENSG00000116062, HSAP, HNPCC5
20 results:
1. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer].
Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766
[No Abstract] [Full Text] [Related]
2. Clinical Characteristics and Responses to Immune Checkpoint Inhibitors in RET-Aberrant Digestive Tract Tumours.
Yen CC; Yeh YM; Huang HY; Ting YL; Fu PA; Lin TC; Liu IT; Yen CJ
Target Oncol; 2023 Jul; 18(4):611-623. PubMed ID: 37347391
[TBL] [Abstract] [Full Text] [Related]
3. Cathepsin F genetic mutation is associated with familial papillary thyroid cancer.
Wang Y; Mei J; Zhang Y; He X; Zheng X; Tan J; Jia Q; Li N; Li D; Wang Y; Meng Z
Am J Med Sci; 2022 Oct; 364(4):414-424. PubMed ID: 35447134
[TBL] [Abstract] [Full Text] [Related]
4. Correlation of mismatch repair deficiency with clinicopathological features and programmed death-ligand 1 expression in thyroid carcinoma.
Qiao PP; Tian KS; Han LT; Ma B; Shen CK; Zhao RY; Zhang Y; Wei WJ; Chen XP
Endocrine; 2022 Jun; 76(3):660-670. PubMed ID: 35366156
[TBL] [Abstract] [Full Text] [Related]
5. New Perspectives on the Recurrent Monoallelic Germline Mutations of DNA Repair and Checkpoint Genes and Clinical Variability.
Sahin I; Saat H
Genet Test Mol Biomarkers; 2022 Jan; 26(1):17-25. PubMed ID: 35089076
[No Abstract] [Full Text] [Related]
6. Co-Occurrence of Familial Non-Medullary thyroid cancer (FNMTC) and Hereditary Non-Polyposis Colorectal cancer (HNPCC) Associated Tumors-A Cohort Study.
Aswath K; Welch J; Gubbi S; Veeraraghavan P; Avadhanula S; Gara SK; Dikoglu E; Merino M; Raffeld M; Xi L; Kebebew E; Klubo-Gwiezdzinska J
Front Endocrinol (Lausanne); 2021; 12():653401. PubMed ID: 34326811
[TBL] [Abstract] [Full Text] [Related]
7. Somatic Mutation Profiling of Papillary thyroid Carcinomas by Whole-exome Sequencing and Its Relationship with Clinical Characteristics.
Qi T; Rong X; Feng Q; Sun H; Cao H; Yang Y; Feng H; Zhu L; Wang L; Du Q
Int J Med Sci; 2021; 18(12):2532-2544. PubMed ID: 34104084
[TBL] [Abstract] [Full Text] [Related]
8. Alteration of DNA mismatch repair capacity underlying the co-occurrence of non-small-cell lung cancer and nonmedullary thyroid cancer.
Fujita S; Masago K
Sci Rep; 2021 Feb; 11(1):3597. PubMed ID: 33574476
[TBL] [Abstract] [Full Text] [Related]
9. msh6/2 and PD-L1 Expressions Are Associated with Tumor Growth and Invasiveness in Silent Pituitary Adenoma Subtypes.
Uraki S; Ariyasu H; Doi A; Takeshima K; Morita S; Inaba H; Furuta H; Fukuhara N; Inoshita N; Nishioka H; Nakao N; Yamada S; Akamizu T
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325698
[TBL] [Abstract] [Full Text] [Related]
10. Comprehensive Immune Profiling of Medullary thyroid cancer.
Pozdeyev N; Erickson TA; Zhang L; Ellison K; Rivard CJ; Sams S; Hirsch FR; Haugen BR; French JD
Thyroid; 2020 Sep; 30(9):1263-1279. PubMed ID: 32242507
[No Abstract] [Full Text] [Related]
11. thyroid cancer: The Quest for Genetic Susceptibility Involving DNA Repair Genes.
Santos LS; Gomes BC; Bastos HN; Gil OM; Azevedo AP; Ferreira TC; Limbert E; Silva SN; Rueff J
Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31374908
[TBL] [Abstract] [Full Text] [Related]
12. Clinicopathologic Features of Mismatch Repair-Deficient Anaplastic thyroid Carcinomas.
Wong KS; Lorch JH; Alexander EK; Nehs MA; Nowak JA; Hornick JL; Barletta JA
Thyroid; 2019 May; 29(5):666-673. PubMed ID: 30869569
[No Abstract] [Full Text] [Related]
13. Germline TP53 and msh6 mutations implicated in sporadic triple-negative breast cancer (TNBC): a preliminary study.
Yi D; Xu L; Luo J; You X; Huang T; Zi Y; Li X; Wang R; Zhong Z; Tang X; Li A; Shi Y; Rao J; Zhang Y; Sang J
Hum Genomics; 2019 Jan; 13(1):4. PubMed ID: 30630526
[TBL] [Abstract] [Full Text] [Related]
14. Tumor development in Japanese patients with Lynch syndrome.
Saita C; Yamaguchi T; Horiguchi SI; Yamada R; Takao M; Iijima T; Wakaume R; Aruga T; Tabata T; Koizumi K
PLoS One; 2018; 13(4):e0195572. PubMed ID: 29672549
[TBL] [Abstract] [Full Text] [Related]
15. Risk of colorectal polyps and of malignancies in asymptomatic carriers of mutations in the main DNA mismatch repair genes.
Ponz de Leon M; Pedroni M; Pezzi A; Sulce B; Roncucci L; Domati F; Rossi G; Reggiani Bonetti L
Scand J Gastroenterol; 2018 Jan; 53(1):31-37. PubMed ID: 29025352
[TBL] [Abstract] [Full Text] [Related]
16. Primary multiple tumor with affection of the thyroid gland, uterus, urinary bladder, mammary gland and other organs.
Romaniuk А; Lyndin M; Smiyanov V; Sikora V; Rieznik A; Kuzenko Y; Budko H; Moskalenko Y; Karpenko L; Sikora V; Gladchenko O
Pathol Res Pract; 2017 May; 213(5):574-579. PubMed ID: 28214212
[TBL] [Abstract] [Full Text] [Related]
17. Targeted DNA Sequencing Detects Mutations Related to Susceptibility among Familial Non-medullary thyroid cancer.
Yu Y; Dong L; Li D; Chuai S; Wu Z; Zheng X; Cheng Y; Han L; Yu J; Gao M
Sci Rep; 2015 Nov; 5():16129. PubMed ID: 26530882
[TBL] [Abstract] [Full Text] [Related]
18. Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing.
Kunstman JW; Juhlin CC; Goh G; Brown TC; Stenman A; Healy JM; Rubinstein JC; Choi M; Kiss N; Nelson-Williams C; Mane S; Rimm DL; Prasad ML; Höög A; Zedenius J; Larsson C; Korah R; Lifton RP; Carling T
Hum Mol Genet; 2015 Apr; 24(8):2318-29. PubMed ID: 25576899
[TBL] [Abstract] [Full Text] [Related]
19. cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry.
Pande M; Wei C; Chen J; Amos CI; Lynch PM; Lu KH; Lucio LA; Boyd-Rogers SG; Bannon SA; Mork ME; Frazier ML
Fam Cancer; 2012 Sep; 11(3):441-7. PubMed ID: 22714864
[TBL] [Abstract] [Full Text] [Related]
20. Infrequent frameshift mutations of polynucleotide repeats in multiple primary cancers affecting the esophagus and other organs.
Iwaya T; Maesawa C; Nishizuka S; Suzuki Y; Sakata K; Sato N; Ikeda K; Koeda K; Ogasawara S; Otsuka K; Kimura Y; Aoki K; Ishida K; Saito K; Tamura G
Genes Chromosomes Cancer; 1998 Dec; 23(4):317-22. PubMed ID: 9824204
[TBL] [Abstract] [Full Text] [Related]
